Skip to Content
Morningstar

iShares Paris-Aligned ClmMSCIWldExUSAETF PABD

Morningstar Medalist Rating
Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis PABD

Will PABD outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable PABD’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the PABD management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of PABD’s parent organization’s priorities and whether they’re in line with investors’ interests.

A sound investment process and strong management team underpin iShares Paris-Aligned ClmMSCIWldExUSAETF's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PABD

More PABD Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 14.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.41 1.3 Mil
Healthcare

ASML Holding NV

2.10 1.2 Mil
Technology

Schneider Electric SE

1.66 917,273
Industrials

Tokyo Electron Ltd

1.43 791,308
Technology

Lvmh Moet Hennessy Louis Vuitton SE

1.31 724,535
Consumer Cyclical

ABB Ltd

1.29 713,803
Industrials

AstraZeneca PLC

1.28 708,769
Healthcare

Novartis AG Registered Shares

1.21 669,305
Healthcare

SAP SE

1.13 625,442
Technology

Roche Holding AG

1.06 584,656
Healthcare